health

Time for change in CKD assessment, treatment

Chronic kidney disease is becoming more prevalent, but early diagnosis is tricky.

By Victoria Stagg Elliott — Posted June 11, 2007

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

To improve the detection and management of the growing number of patients with chronic kidney disease, the formula commonly used for diagnosis and staging needs to be refined, according to a session at the American Society of Hypertension scientific meeting in Chicago last month.

"We need to address the issues of estimating glomerular filtration rate and quantifying albuminuria/proteinuria," said Matthew R. Weir, MD, one of the speakers and director of the division of nephrology at the University of Maryland School of Medicine in Baltimore.

Experts complained that the Modification of Diet in Renal Disease -- or MDRD -- formula used to estimate the GFR is not as accurate at the earlier stages of chronic kidney disease or for patients who are older. The tool is too reliant on creatinine, which can be affected by a person's size and muscle mass. The laboratory assays for this waste product are not standardized, although the issue is one on which the National Kidney Disease Education Program is working.

"It's very good for GFRs below 60, but there's a lot of imprecision in people with GFRs above 60," said Edgar R. Miller, MD, PhD, who also spoke at the session and is an associate professor of medicine in the division of general internal medicine at Johns Hopkins University in Baltimore.

A paper suggesting a revised formula incorporating cystatin C, an indicator of renal function, is expected to be published sometime over the next year or so, although many experts feel it will take far more than just one additional marker to improve the formula's utility.

"There has not been great confidence that cystatin C alone will improve estimating GFR, but it is being talked about," Dr. Miller said. "I'm sure cystatin C will be become part of an assessment."

On the management end, experts also are advocating treatment approaches, such as the use of angiotensin-converting enzyme inhibitors, that better protect the heart of these patients.

"The sicker the kidney, the greater the advantage of ACE inhibition," Dr. Weir said. "The kidney and the heart are very closely tied together by the same pipes, and it's clear that once that GFR starts to fall, the [cardiovascular disease] events increase. These are people who need global CVD risk reduction measures."

These medications often are used with hesitation as kidney disease progresses, although experts said they could be used safely if nonsteroidal anti-inflammatories and foods high in potassium were avoided.

"There's anxiety about treating people with higher creatinine with ACE inhibitors," Dr. Weir said. "It's not justified." He said his advice applied to most CKD patients except those who were in the end stages of their disease.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn